These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17551994)

  • 21. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS
    Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An appraisal of dual antiplatelet therapy with clopidogrel and aspirin for prevention of cardiovascular events.
    Terpening C
    J Am Board Fam Med; 2009; 22(1):51-6. PubMed ID: 19124633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The economic consequences of non-evidence-based clopidogrel use.
    Choudhry NK; Levin R; Avorn J
    Am Heart J; 2008 May; 155(5):904-9. PubMed ID: 18440340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for using clopidogrel alone or in addition to aspirin in post coronary artery bypass surgery patients.
    Patel JH; Stoner JA; Owora A; Mathew ST; Thadani U
    Am J Cardiol; 2009 Jun; 103(12):1687-93. PubMed ID: 19539077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
    Hermosillo AJ; Spinler SA
    Ann Pharmacother; 2008 Jun; 42(6):790-805. PubMed ID: 18477734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z; Kala P
    Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
    Pride YB; Wiviott SD; Buros JL; Zorkun C; Tariq MU; Antman EM; Braunwald E; Gibson CM;
    Am Heart J; 2009 Sep; 158(3):e21-6. PubMed ID: 19699846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
    Hermann A; Dzialowski I; Koch R; Gahn G
    J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of prasugrel compared with clopidogrel in patients with acute coronary syndromes: results of TRITON-TIMI 38 trials.
    Mariani M; Mariani G; De Servi S
    Expert Rev Cardiovasc Ther; 2009 Jan; 7(1):17-23. PubMed ID: 19105763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.
    Toth PP
    Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current standings of the proton pump inhibitor and clopidogrel co-therapy: review on an evolving field with the eyes of the gastroenterologist.
    Juhász M; Herszényi L; Tulassay Z
    Digestion; 2010; 81(1):10-5. PubMed ID: 20029203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspirin plus clopidogrel and risk of infection after coronary artery bypass surgery.
    Blasco-Colmenares E; Perl TM; Guallar E; Baumgartner WA; Conte JV; Alejo D; Pastor-Barriuso R; Sharrett AR; Faraday N
    Arch Intern Med; 2009 Apr; 169(8):788-96. PubMed ID: 19398691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes.
    Storey RF; Husted S; Harrington RA; Heptinstall S; Wilcox RG; Peters G; Wickens M; Emanuelsson H; Gurbel P; Grande P; Cannon CP
    J Am Coll Cardiol; 2007 Nov; 50(19):1852-6. PubMed ID: 17980251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single antiplatelet therapy for patients with previous gastrointestinal bleeds.
    Gellatly RM; Ackman ML
    Ann Pharmacother; 2008 Jun; 42(6):836-40. PubMed ID: 18413689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clopidogrel: who, when, and how?
    Cannon CP
    Rev Cardiovasc Med; 2007; 8 Suppl 3():S27-34. PubMed ID: 17917618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.
    Antman EM; Wiviott SD; Murphy SA; Voitk J; Hasin Y; Widimsky P; Chandna H; Macias W; McCabe CH; Braunwald E
    J Am Coll Cardiol; 2008 May; 51(21):2028-33. PubMed ID: 18498956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of bleeding complications with omega-3 fatty acids + aspirin + clopidogrel--versus--aspirin + clopidogrel in patients with cardiovascular disease.
    Watson PD; Joy PS; Nkonde C; Hessen SE; Karalis DG
    Am J Cardiol; 2009 Oct; 104(8):1052-4. PubMed ID: 19801023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial.
    James S; Akerblom A; Cannon CP; Emanuelsson H; Husted S; Katus H; Skene A; Steg PG; Storey RF; Harrington R; Becker R; Wallentin L
    Am Heart J; 2009 Apr; 157(4):599-605. PubMed ID: 19332184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis.
    Berger JS; Frye CB; Harshaw Q; Edwards FH; Steinhubl SR; Becker RC
    J Am Coll Cardiol; 2008 Nov; 52(21):1693-701. PubMed ID: 19007688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prasugrel (Effient) vs. clopidogrel (Plavix).
    Med Lett Drugs Ther; 2009 Sep; 51(1320):69-70. PubMed ID: 19738549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.